Large-scale testing (Phase 3)Ended earlyNCT01524887What this trial is testingPhase 3 IGIV, 10% in Alzheimer´s DiseaseWho this might be right forAlzheimer´s Disease Baxalta now part of Shire 508
Large-scale testing (Phase 3)Ended earlyNCT00667810What this trial is testingStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 901
Testing effectiveness (Phase 2)Looking for participantsNCT07367815What this trial is testingAllogeneic Adipose Tissue Derived-stem Cells in Alzheimer DiseaseWho this might be right forAlzheimer Disease University Hospital, Toulouse 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050What this trial is testingBrainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimers Disease Hoffmann-La Roche 241
Not applicableNot Yet RecruitingNCT05575271What this trial is testingImplantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD PatientsWho this might be right forAlzheimer Disease Xuanwu Hospital, Beijing 6
Testing effectiveness (Phase 2)Study completedNCT02907567What this trial is testingClinical Trial of CT1812 in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Cognition Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT05811442What this trial is testingStudy of 50561 in Patients With Mild or Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Beijing Joekai Biotechnology LLC 68
Not applicableStudy completedNCT01089582What this trial is testingQuality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept TabletsWho this might be right forAlzheimer Disease Pfizer 628
Large-scale testing (Phase 3)Study completedNCT00231946What this trial is testingALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)Who this might be right forAlzheimer's Disease Voyager Pharmaceutical Corporation 555
Early research (Phase 1)Study completedNCT01837641What this trial is testingLY3002813 in Participants With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Eli Lilly and Company 63
Large-scale testing (Phase 3)UnknownNCT00088673What this trial is testingEvaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Bellus Health Inc. - a GSK company 950
Testing effectiveness (Phase 2)Study completedNCT00959192What this trial is testingSafety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 32
Post-approval studies (Phase 4)Looking for participantsNCT05908695What this trial is testingAn Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 1,312
Testing effectiveness (Phase 2)Study completedNCT01527916What this trial is testingEvaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 438
Testing effectiveness (Phase 2)UnknownNCT02833792What this trial is testingAllogeneic Human Mesenchymal Stem Cells for Alzheimer's DiseaseWho this might be right forAlzheimer Dementia Stemedica Cell Technologies, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04070378What this trial is testingStudy of Daratumumab in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Marc L Gordon, MD 16
Not applicableStudy completedNCT01081743What this trial is testingEffectiveness of Care Management in Alzheimer PatientsWho this might be right forAlzheimer Disease or Associated DisorderMild to Moderately Severe Dementia Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Large-scale testing (Phase 3)Study completedNCT04669028What this trial is testingNE3107 in Probable Alzheimer's DiseaseWho this might be right forAlzheimer Disease BioVie Inc. 439
Testing effectiveness (Phase 2)Study completedNCT00812565What this trial is testingStudy of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Octapharma 58
Testing effectiveness (Phase 2)Study completedNCT00568776What this trial is testingELND005 in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease OPKO Health, Inc. 353